Antiprogestin treatment decreases midluteal luteinizing hormone pulse amplitude and primarily exerts a pituitary inhibition
- 1 December 1990
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 163 (6) , 1982-1985
- https://doi.org/10.1016/0002-9378(90)90784-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Acute Effects of Progesterone and the Antiprogestin RU 486 on Gonadotropin Secretion in the Follicular Phase of the Menstrual Cycle*Journal of Clinical Endocrinology & Metabolism, 1989
- Effects of an Antiprogesterone (RU486) on the Hypothalamic-Hypophyseal-Ovarian-Endometrial Axis During the Luteal Phase of the Menstrual Cycle*Journal of Clinical Endocrinology & Metabolism, 1988
- Effects of the antiprogesterone RU 486 in normal womenAmerican Journal of Obstetrics and Gynecology, 1987
- Effects of the antiprogesterone RU 486 in normal womenAmerican Journal of Obstetrics and Gynecology, 1987
- The Progesterone Antagonist RU 486New England Journal of Medicine, 1987
- Effect of the antiprogestin RU486 on progesterone production by cultured human granulosa cells: Inhibition of the ovarian 3B-Hydroxysteroid dehydrogenaseContraception, 1986
- Effects of the Antiprogesterone Steroid RU 486 during Midluteal Phase in Normal WomenJournal of Clinical Endocrinology & Metabolism, 1985
- Increased Adrenocorticotropin, Cortisol, and Arginine Vasopressin Secretion in Primates after the Antiglucocorticoid Steroid RU 486:Dose Response Relationships*Journal of Clinical Endocrinology & Metabolism, 1985
- The New Steroid Analog RU 486 Inhibits Glucocorticoid Action in ManJournal of Clinical Endocrinology & Metabolism, 1984
- Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion.Journal of Clinical Investigation, 1984